QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)

Apexigen Stock Price, News & Analysis (NASDAQ:APGNW)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.02
▼
$0.03
50-Day Range
$0.02
▼
$0.05
52-Week Range
$0.01
▼
$0.37
Volume
3,100 shs
Average Volume
17,375 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisHeadlinesShort InterestSocial Media

APGNW stock logo

About Apexigen Stock (NASDAQ:APGNW)

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.


APGNW Stock News Headlines

August 11, 2023 | businesswire.com
APEXIGEN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apexigen, Inc ...
June 3, 2023 | benzinga.com
Lifshitz Law PLLC Announces Investigations of APGN, GNL, RTL, and BACK
November 28, 2023 | RYSE INC. (Ad)
Secure your stake in the Smart Home industry.
Last chance to invest in RYSE – the shade automation technology launching in over 100 Best Buy stores this month.
May 27, 2023 | benzinga.com
Apexigen Stock (NASDAQ:APGN), Insider Trading Activity
May 25, 2023 | msn.com
Apexigen (APGN) to Get Acquired by Pyxis Oncology, Stock Up
May 25, 2023 | msn.com
EF Hutton Downgrades Apexigen (APGN)
May 24, 2023 | theglobeandmail.com
Biotech Soars On Acquisition Announcement
May 24, 2023 | msn.com
Small SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16M
November 28, 2023 | RYSE INC. (Ad)
Secure your stake in the Smart Home industry.
Last chance to invest in RYSE – the shade automation technology launching in over 100 Best Buy stores this month.
May 24, 2023 | investorplace.com
Why Is Apexigen (APGN) Stock Up 31% Today?
May 24, 2023 | msn.com
US Futures Lower as Investors Eye Debt Ceiling Talks, Await Fed Minutes Release
May 24, 2023 | finance.yahoo.com
Pyxis Oncology to Acquire Apexigen
May 24, 2023 | msn.com
Apexigen surges ~40% on all-stock acquisition by Pyxis Oncology
May 24, 2023 | technews.tmcnet.com
APGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apexigen, Inc. Is Fair to Shareholders
February 27, 2023 | bizjournals.com
Months after going public, Peninsula biotech cuts staff, weights its options for future
February 27, 2023 | bizjournals.com
Months after going public, Peninsula biotech Apexigen cuts staff, weighs its options for future
See More Headlines
Receive APGNW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apexigen and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:APGNW
CUSIP
N/A
CIK
1814140
Web
www.apexigen.com
Phone
650-931-6236
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Xiaodong Yang M.D. (Age 62)
    Ph.D., Pres, CEO & Director
    Comp: $541.33k
  • Ms. Amy Wong (Age 56)
    Sr. VP of Fin. & Operations
    Comp: $368.92k
  • Dr. Frank J. Hsu M.D. (Age 61)
    Chief Medical Officer
    Comp: $212.19k
  • Mr. William E. Duke Jr. (Age 50)
    Chief Financial Officer
  • Mr. Francis W. Sarena (Age 51)
    Chief Operating Officer
  • Dr. Jason Wright Ph.D.
    Sr. VP of CMC

Key Competitors

View All Competitors














APGNW Stock Analysis - Frequently Asked Questions

Who are Apexigen's major shareholders?

Apexigen's stock is owned by many different institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).

This page (NASDAQ:APGNW) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -